BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rakotosamimanana N, Richard V, Raharimanga V, Gicquel B, Doherty TM, Zumla A, Rasolofo Razanamparany V. Biomarkers for risk of developing active tuberculosis in contacts of TB patients: a prospective cohort study. Eur Respir J 2015;46:1095-103. [PMID: 26250497 DOI: 10.1183/13993003.00263-2015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Basu Roy R, Whittaker E, Seddon JA, Kampmann B. Tuberculosis susceptibility and protection in children. Lancet Infect Dis 2019;19:e96-e108. [PMID: 30322790 DOI: 10.1016/S1473-3099(18)30157-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
2 Stefanescu S, Cocoș R, Turcu-Stiolica A, Shelby ES, Matei M, Subtirelu MS, Meca AD, Stanciulescu EC, Popescu SO, Biciusca V, Pisoschi CG. Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results. Pathogens 2021;10:789. [PMID: 34206598 DOI: 10.3390/pathogens10070789] [Reference Citation Analysis]
3 Buttle TS, Hummerstone CY, Billahalli T, Ward RJB, Barnes KE, Marshall NJ, Spong VC, Bothamley GH. The monocyte-to-lymphocyte ratio: Sex-specific differences in the tuberculosis disease spectrum, diagnostic indices and defining normal ranges. PLoS One 2021;16:e0247745. [PMID: 34460817 DOI: 10.1371/journal.pone.0247745] [Reference Citation Analysis]
4 Burel JG, Singhania A, Dubelko P, Muller J, Tanner R, Parizotto E, Dedicoat M, Fletcher TE, Dunbar J, Cunningham AF, Lindestam Arlehamn CS, Catanzaro DG, Catanzaro A, Rodwell T, McShane H, O'Shea MK, Peters B. Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease. Tuberculosis (Edinb) 2021;131:102127. [PMID: 34555657 DOI: 10.1016/j.tube.2021.102127] [Reference Citation Analysis]
5 Scriba TJ, Coussens AK, Fletcher HA. Human Immunology of Tuberculosis. Microbiol Spectr 2017;5. [PMID: 28155806 DOI: 10.1128/microbiolspec.TBTB2-0016-2016] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
6 Burel JG, Qian Y, Lindestam Arlehamn C, Weiskopf D, Zapardiel-Gonzalo J, Taplitz R, Gilman RH, Saito M, de Silva AD, Vijayanand P, Scheuermann RH, Sette A, Peters B. An Integrated Workflow To Assess Technical and Biological Variability of Cell Population Frequencies in Human Peripheral Blood by Flow Cytometry. J Immunol 2017;198:1748-58. [PMID: 28069807 DOI: 10.4049/jimmunol.1601750] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
7 Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, Codecasa LR, Cugnata F, Di Serio C, Ferrarese M, Goletti D, Lipman M, Rancoita PM, Russo G, Tadolini M, Vanino E, Cirillo DM. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening. Eur Respir J 2016;48:1411-9. [DOI: 10.1183/13993003.00510-2016] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 13.3] [Reference Citation Analysis]
8 Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, Ottenhoff TH, Denkinger CM, Goletti D. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur Respir J 2016;48:1751-63. [PMID: 27836953 DOI: 10.1183/13993003.01012-2016] [Cited by in Crossref: 114] [Cited by in F6Publishing: 107] [Article Influence: 19.0] [Reference Citation Analysis]
9 Hijikata M, Matsushita I, Le Hang NT, Thuong PH, Tam DB, Maeda S, Sakurada S, Cuong VC, Lien LT, Keicho N. Influence of the polymorphism of the DUSP14 gene on the expression of immune-related genes and development of pulmonary tuberculosis. Genes Immun 2016;17:207-12. [DOI: 10.1038/gene.2016.11] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
10 Piergallini TJ, Scordo JM, Pino PA, Schlesinger LS, Torrelles JB, Turner J. Acute Inflammation Confers Enhanced Protection against Mycobacterium tuberculosis Infection in Mice. Microbiol Spectr 2021;9:e0001621. [PMID: 34232086 DOI: 10.1128/Spectrum.00016-21] [Reference Citation Analysis]
11 Estévez O, Anibarro L, Garet E, Pallares Á, Barcia L, Calviño L, Maueia C, Mussá T, Fdez-Riverola F, Glez-Peña D, Reboiro-Jato M, López-Fernández H, Fonseca NA, Reljic R, González-Fernández Á. An RNA-seq Based Machine Learning Approach Identifies Latent Tuberculosis Patients With an Active Tuberculosis Profile. Front Immunol 2020;11:1470. [PMID: 32760401 DOI: 10.3389/fimmu.2020.01470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Adankwah E, Harelimana JD, Minadzi D, Aniagyei W, Abass MK, Batsa Debrah L, Owusu DO, Mayatepek E, Phillips RO, Jacobsen M. Lower IL-7 Receptor Expression of Monocytes Impairs Antimycobacterial Effector Functions in Patients with Tuberculosis. J Immunol 2021;206:2430-40. [PMID: 33911006 DOI: 10.4049/jimmunol.2001256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sousa J, Saraiva M. Paradigm changing evidence that alter tuberculosis perception and detection: Focus on latency. Infect Genet Evol 2019;72:78-85. [PMID: 30576838 DOI: 10.1016/j.meegid.2018.12.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Gough M, Singh DK, Moodley C, Niu T, Golden NA, Kaushal D, Mehra S. Peripheral Blood Markers Correlate with the Progression of Active Tuberculosis Relative to Latent Control of Mycobacterium tuberculosis Infection in Macaques. Pathogens 2022;11:544. [DOI: 10.3390/pathogens11050544] [Reference Citation Analysis]
15 Zellweger JP, Sotgiu G, Corradi M, Durando P. The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB). Med Lav 2020;111:170-83. [PMID: 32624559 DOI: 10.23749/mdl.v111i3.9983] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 Van Ginderdeuren E, Bassett J, Hanrahan CF, Van Rie A. Association between monocyte-to-lymphocyte ratio and tuberculin skin test positivity in HIV-positive adults. PLoS One 2021;16:e0253907. [PMID: 34270562 DOI: 10.1371/journal.pone.0253907] [Reference Citation Analysis]
17 Lewinsohn DM, Lewinsohn DA. New Concepts in Tuberculosis Host Defense. Clin Chest Med 2019;40:703-19. [PMID: 31731979 DOI: 10.1016/j.ccm.2019.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Goletti D, Lindestam Arlehamn CS, Scriba TJ, Anthony R, Cirillo DM, Alonzi T, Denkinger CM, Cobelens F. Can we predict tuberculosis cure? What tools are available? Eur Respir J 2018;52:1801089. [PMID: 30361242 DOI: 10.1183/13993003.01089-2018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
19 Siddhi P, Raveendranath R, Pulgari P, Chinnaswamy A, Song R, Welch S. A systematic review on Correlates of Risk of TB disease in children and adults. Indian Journal of Tuberculosis 2022. [DOI: 10.1016/j.ijtb.2022.05.001] [Reference Citation Analysis]
20 Chedid C, Kokhreidze E, Tukvadze N, Banu S, Uddin MKM, Biswas S, Russomando G, Acosta CCD, Arenas R, Ranaivomanana PP, Razafimahatratra C, Herindrainy P, Rakotosamimanana N, Hamze M, Ismail MB, Bayaa R, Berland JL, Delogu G, Endtz H, Ader F, Goletti D, Hoffmann J; HINTT working group within the GABRIEL network. Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study. Int J Infect Dis 2020;100:199-206. [PMID: 32920230 DOI: 10.1016/j.ijid.2020.09.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 Wang W, Wang LF, Liu YY, Yang F, Zhu L, Zhang XH. Value of the Ratio of Monocytes to Lymphocytes for Monitoring Tuberculosis Therapy. Can J Infect Dis Med Microbiol 2019;2019:3270393. [PMID: 31263513 DOI: 10.1155/2019/3270393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
22 Mburu JW, Kingwara L, Ester M, Andrew N. Prognostic factors among TB and TB/DM comorbidity among patients on short course regimen within Nairobi and Kiambu counties in Kenya. J Clin Tuberc Other Mycobact Dis 2018;12:9-13. [PMID: 31720392 DOI: 10.1016/j.jctube.2018.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Sampath P, Moideen K, Ranganathan UD, Bethunaickan R. Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection. Front Immunol 2018;9:1726. [PMID: 30105020 DOI: 10.3389/fimmu.2018.01726] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 15.8] [Reference Citation Analysis]
24 Kang YJ, Park H, Park SB, Kim J, Lee J, Kim J, Park S, Lee YS, Kim S. Combined analysis of whole blood interferon gamma release assay and complete blood count analysis for rapid discrimination of active tuberculosis and latent tuberculosis infection. J Clin Tuberc Other Mycobact Dis 2021;24:100253. [PMID: 34278005 DOI: 10.1016/j.jctube.2021.100253] [Reference Citation Analysis]
25 Sadananda G, Knoblauch AM, Andriamiadanarivo A, Razafindrina K, Ambinintsoa I, Rabetombosoa RM, Pando CE, Tsang LY, Small PM, Rakotosamimanana N, Grandjean Lapierre S. Latent tuberculosis infection prevalence in rural Madagascar. Trans R Soc Trop Med Hyg 2020;114:883-5. [PMID: 33140102 DOI: 10.1093/trstmh/traa054] [Reference Citation Analysis]